{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial., Tobback, Els, Degroote Sophie, Buysse Sabine, Delesie Liesbeth, Van Dooren Lucas, Vanherrewege Sophie, Barbezange Cyril, Hutse Veronik, Romano Marta, Thomas Isabelle, et al. , Int J Infect Dis, 2022 Sep, Volume 122, (2022)\par \par }